n Southern African Journal of HIV Medicine - Influenza immunisation in HIV-infected persons : fighting flu
|Article Title||Influenza immunisation in HIV-infected persons : fighting flu|
|Journal||Southern African Journal of HIV Medicine|
|Author||Barry D. Schoub|
|Publication Date||Jan 2001|
|Pages||15 - 17|
|Keyword(s)||University of Witwatersrand|
Influenza vaccines are widely used throughout the world. Some 80 - 85 million doses are produced annually for distribution in the USA alone where coverage for the major risk group, persons over 65 years of age, was 63% in 1997 (surpassing the 6O% vaccine coverage goal for the country's Healthy People 2000 Project). The clinical effectiveness as well as the cost effectiveness of influenza vaccines have been clearly established in a number of studies in many parts of the world. Influenza vaccination has also been demonstrated to reduce hospitalisation significantly in elderly high-risk persons. In South Africa, influenza immunisation has similarly been demonstrated to be cost effective and utilisation of vaccine in this country has increased markedly over the past few years, reaching over 2 million doses administered in 2000. Annual influenza immunisation is sound preventive medicine generally, and in particular is mandated for persons at risk for complications of influenza.
Article metrics loading...